EyePoint Pharmaceuticals, Inc. (EYPT): Price and Financial Metrics
EYPT Price/Volume Stats
Current price | $10.65 | 52-week high | $30.99 |
Prev. close | $11.11 | 52-week low | $5.86 |
Day low | $10.62 | Volume | 259,282 |
Day high | $11.39 | Avg. volume | 933,903 |
50-day MA | $9.67 | Dividend yield | N/A |
200-day MA | $14.13 | Market Cap | 569.97M |
EYPT Stock Price Chart Interactive Chart >
EyePoint Pharmaceuticals, Inc. (EYPT) Company Bio
EyePoint Pharmaceuticals (formerly pSivida Corp.) develops sustained-release drug-delivery products for treating eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior uveitis. The company was founded in 1987 and is based in Watertown, Massachusetts.
EYPT Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching EYPT
Here are a few links from around the web to help you further your research on EyePoint Pharmaceuticals Inc's stock as an investment opportunity:EyePoint Pharmaceuticals Inc (EYPT) Stock Price | Nasdaq
EyePoint Pharmaceuticals Inc (EYPT) Stock Quote, History and News - Yahoo Finance
EyePoint Pharmaceuticals Inc (EYPT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...